CEP290 and Leber congenital amaurosis: The fact that our mouse model did not show the aberrant splicing of CEP290 that is characteristic of the LCA-causing intronic mutation, prevents us to study the exact pathophysiological mechanisms as well as to test pre-clinical efficacy of AON-based splice correction therapy [9,33].